Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia.
Adv Sci (Weinh). 2024 Mar;11(11):e2305885. doi: 10.1002/advs.202305885. Epub 2023 Dec 31.
Adv Sci (Weinh). 2024.
PMID: 38161214
Free PMC article.
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Chen N, Pan J, Zhou Y, Mao L, Lou Y, Qian J, Xu G, Wei J, Zhou D, Shou L, Huang L, Yan M, Zeng H, Fan C, Wu G, Feng W, Tong H, Jin J, Wang H.
Chen N, et al.
Br J Haematol. 2024 Mar;204(3):861-870. doi: 10.1111/bjh.19182. Epub 2023 Nov 8.
Br J Haematol. 2024.
PMID: 37939390
Item in Clipboard
Identification of a novel NPM1 mutation in acute myeloid leukemia.
Yao Y, Lin X, Wang C, Gu Y, Jin J, Zhu Y, Wang H.
Yao Y, et al.
Exp Hematol Oncol. 2023 Oct 4;12(1):87. doi: 10.1186/s40164-023-00449-4.
Exp Hematol Oncol. 2023.
PMID: 37794441
Free PMC article.
Item in Clipboard
Cite
Cite